Catalent is a U.S.-based global contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotech, and consumer health sectors. Headquartered in Somerset, New Jersey, it provides development, scale-up, and commercial manufacturing across a network of facilities in the Americas, Europe, and Asia.
The company’s capabilities span formulation and analytical services; oral dose and drug delivery technologies such as softgel capsules (including plant-based options), oral solid dose and modified-release forms, and orally disintegrating tablets; as well as sterile fill–finish and biologics manufacturing for proteins and advanced therapies. Catalent also offers clinical supply management, packaging, and serialization services supporting global launches.
Its operations cover prescription and over-the-counter medicines, nutritional supplements, and animal health products, with contained processing for highly potent and cytotoxic compounds. The company is also referred to as Catalent Pharma Solutions in connection with many of its service offerings.
Also known as Catalent Pharma Solutions.
chemXplore tracks 1 project involving Catalent.
Catalent's role on them: Owner.
Ricardo Pravda, with 25+ years in HR, joins from Hikma Pharmaceuticals to lead global HR strategy, focusing on culture, talent, and growth.
The $14M expansion in Eberbach includes new Vegicaps® lines, printing tech, vision inspection, coating, and packaging. Workforce to grow by 10% to meet rising demand for animal-free health products.
By country, the most active first. active / all projects
